160 related articles for article (PubMed ID: 11408350)
1. HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2.
Wächtershäuser A; Akoglu B; Stein J
Carcinogenesis; 2001 Jul; 22(7):1061-7. PubMed ID: 11408350
[TBL] [Abstract][Full Text] [Related]
2. Butyrate-induced differentiation of Caco-2 cells occurs independently from p27.
Wächtershäuser A; Stein J
Biochem Biophys Res Commun; 2001 Feb; 281(2):295-9. PubMed ID: 11181044
[TBL] [Abstract][Full Text] [Related]
3. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
Fouty BW; Rodman DM
Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
[TBL] [Abstract][Full Text] [Related]
4. [In vitro effects of mevastatin on the proliferation and apoptosis in human multiple myeloma cell line U266].
Liu ZL; Luo JM; Dong ZR; Wang FX; Zhang XJ; Yang JC; Du XY; Yao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):340-5. PubMed ID: 15228663
[TBL] [Abstract][Full Text] [Related]
5. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
Duncan RE; Lau D; El-Sohemy A; Archer MC
Biochem Pharmacol; 2004 Nov; 68(9):1739-47. PubMed ID: 15450939
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.
Rao S; Porter DC; Chen X; Herliczek T; Lowe M; Keyomarsi K
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7797-802. PubMed ID: 10393901
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
[TBL] [Abstract][Full Text] [Related]
8. Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells.
Rasmussen LM; Hansen PR; Nabipour MT; Olesen P; Kristiansen MT; Ledet T
Biochem J; 2001 Dec; 360(Pt 2):363-70. PubMed ID: 11716764
[TBL] [Abstract][Full Text] [Related]
9. Mevastatin, an inhibitor of HMG-CoA reductase, induces apoptosis, differentiation and Rap1 expression in HL-60 cells.
Kanno T; Kobuchi H; Kajitani N; Utsumi T; Yano H; Horton AA; Yasuda T; Utsumi K
Physiol Chem Phys Med NMR; 2002; 34(1):1-15. PubMed ID: 12403272
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
11. Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice.
Velázquez OC; Jabbar A; DeMatteo RP; Rombeau JL
Surgery; 1996 Aug; 120(2):440-7; discussion 447-8. PubMed ID: 8751616
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cdk2 activating phosphorylation by mevastatin.
Ukomadu C; Dutta A
J Biol Chem; 2003 Feb; 278(7):4840-6. PubMed ID: 12475985
[TBL] [Abstract][Full Text] [Related]
13. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Roelofs AJ; Edwards CM; Russell RG; Ebetino FH; Rogers MJ; Hulley PA
J Pharmacol Exp Ther; 2007 Jul; 322(1):228-35. PubMed ID: 17412884
[TBL] [Abstract][Full Text] [Related]
14. Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells.
Zhang S; Wang XL; Gan YH; Li SL
Anticancer Drugs; 2010 Aug; 21(7):678-86. PubMed ID: 20629200
[TBL] [Abstract][Full Text] [Related]
15. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection.
Gaschott T; Stein J
Recent Results Cancer Res; 2003; 164():247-57. PubMed ID: 12899527
[TBL] [Abstract][Full Text] [Related]
16. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
Alberts AW
Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
[TBL] [Abstract][Full Text] [Related]
19. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
Peffley DM; Gayen AK
J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
